Through presentations from Notified Body and Industry experts, real-world case studies, and interactive discussions, you will learn how to navigate the interdependencies between PMS, clinical evidence and risk management processes with particular focus on DDC products.

NEW OFFERING! Understanding Real World Evidence (RWE) and Observational studies using Real World Data (RWD) has become necessary not only for people working in pharmacovigilance but to everyone working in all stages of the lifecycle of medicines.